Delivery Order SPE2DB24D8002-SPE2DB25FJNFG
Award Date
2/26/25
Potential Completion Date
2/27/25
Potential Value
$6.8K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) Troop Support Medical division. The $1,443.39 firm fixed-price contract is for the delivery of ENTRESTO 49 MG-51 MG TABLET 60S, a pharmaceutical product. This award is part of Dakota Drug's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA under the ECAT Generation V Program, which allows the company to provide a wide range of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,073.07 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of ENTRESTO 24 MG-26 MG TABLET 60S. This award is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, under the DLA Troop Support Medical's ECAT Generation V Program. The contract, which does not have a set-aside designation, allows Dakota Drug, Inc....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,052.23, is for the delivery of ENTRESTO 49 MG-51 MG tablets to support U.S. Armed Forces medical operations. The award is part of the DLA Troop Support Medical's ECAT Generation V Program, a larger indefinite delivery contract (IDC) with a ceiling value of $999,999,999.00 that allows Dakota Drug, Inc. to provide...
This federal contract award, valued at $14,527.64, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of ENTRESTO 49 MG-51 MG TABLET 60S. The contract is a firm-fixed-price delivery order with a period of performance through October 29, 2024. Dakota Drug, Inc. is a key supplier to the DLA, holding a significant single-award Indefinite Delivery Contract (IDC) valued at $999,999,999.00 as part of the DLA Troop...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of ENTRESTO 24 MG-26 MG TABLET 60S. The ceiling value of this contract is $2,910.31, with an ultimate completion date of October 21, 2024. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. federal government, particularly the Department of Defense. The...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of ENTRESTO 24 MG-26 MG TABLET 60S pharmaceutical products. The contract has a firm fixed-price, with a ceiling value of $8,811.79 and a period of performance through February 24, 2025. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00....
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract valued at $2,096.48 to Dakota Drug, Inc., a self-certified small disadvantaged business. This contract is for the provision of 97 mg-103 mg ENTRESTO tablets, a medication used to treat conditions such as heart failure. The delivery order was placed under Dakota Drug's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to supply a wide range...
This federal contract award, with a total ceiling value of $13,171.68, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business and for-profit Subchapter S corporation. The contract, identified as SPE2DB24D8001 and SPE2DB24FKZCS, is a delivery order for the provision of the pharmaceutical product ENTRESTO 24 MG-26 MG TABLET 60S. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that allows...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of ENTRESTO 24 MG-26 MG TABLET 60S, a pharmaceutical product. The contract has a ceiling value of $10,729.29 and an ultimate completion date of May 23, 2024. Dakota Drug, Inc. is an established federal contractor, holding a significant single-award Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $6,354.77 firm fixed-price contract is for the delivery of ENTRESTO 24 MG-26 MG TABLET 60S, a pharmaceutical product, with a completion date of September 19, 2023. Dakota Drug, Inc. is a key supplier for the DLA, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) as part of the DLA Troop Support Medical's...